NCLEXTA include:
diarrhea
nausea
low red blood cell count
upper respiratory tract infection
low platelet count
feeling tired
VENCLEXTA may cause fertility problems in males. This may affect your ability to father a child. Talk to your doctor if you have concerns about fertility.
Tell your doctor if you have any side effect that bothers you or that does not go away.
These are not all the possible side effects of VENCLEXTA. For more information, ask your doctor or pharmacist.
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
How should I store VENCLEXTA?
Store VENCLEXTA at or below 86°F (30°C).
Keep VENCLEXTA tablets in the original package during the first 4 weeks of treatment. Do not transfer the tablets to a pillbox or other container.
Keep VENCLEXTA and all medicines out of reach of children.
General information about the safe and effective use of VENCLEXTA.
Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use VENCLEXTA for a condition for which it was not prescribed. Do not give VENCLEXTA to other people, even if they have the same symptoms that you have. It may harm them. You can ask your doctor or pharmacist for information about VENCLEXTA that is written for health professionals.
What are the ingredients in VENCLEXTA?
Active ingredient: venetoclax
Inactive ingredients: copovidone, colloidal silicon dioxide, polysorbate 80, sodium stearyl fumarate, and calcium phosphate dibasic.
The 10 mg and 100 mg coated tablets also include the following: iron oxide yellow, polyvinyl alcohol, polyethylene glycol, talc, titanium dioxide. The 50 mg coated tablets also include the following: iron oxide yellow, iron oxide red, iron oxide black, polyvinvyl alcohol, talc, polyethylene glycol, and titanium dioxide.
Manufactured and Marketed by:
AbbVie Inc.
North Chicago, IL 60064
© 2016 AbbVie Inc.
03-B232
Marketed by:
Genentech USA, Inc.
A member of the Roche Group
South San Francisco, CA 94080-4990
© 2016 Genentech, Inc.
This Medication Guide has been approved by the U.S. Food and Drug Administration. Issued: 04/2016
PRNCIPAL DISPLAY PANEL
NDC 0074–0579–28
Rx only
VENCLEXTA™
(venetoclax) tablets
10 mg, 50 mg, and 100 mg
Starting Pack
! WARNING
Contact your doctor when you receive this medication.
It may be necessary to take your first dose in the presence of your doctor to prevent a potential serious side effect.
DISPENSER: Each time VENCLEXTA is dispensed give the patient the enclosed Medication Guide.
abbvie
Genentech
NDC 0074–0561–14
Rx only
VENCLEXTA™
(venetoclax) tablets
10 mg
14 Tablets
Dispense the accompanying Medication Guide to each patient.
abbvie
Genentech
NDC 0074–0566–11
Rx only
VENCLEXTA™
(venetoclax) tablets
50 mg
1 Tablet
Dispense the accompanying Medication Guide to each patient.
abbvie
Genentech
NDC 0074–0576–22
Rx only
VENCLEXTA™
(venetoclax) tablets
100 mg
120 Tablets
Do not accept if seal over bottle opening is broken or missing
Each film-coated tablet contains 100 mg of venetoclax.
Keep out of reach of children.
Store at or below 86°F (30°C)
abbvi
Genentech
INGREDIENTS AND APPEARANCE
VENCLEXTA
venetoclax kit
Product Information
Product Type HUMAN PRESCRIPTION D |
